Group One Trading’s GenMark Diagnostics, Inc GNMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-45,300
Closed -$1.08M 8862
2021
Q1
$1.08M Sell
45,300
-1,600
-3% -$29.7K ﹤0.01% 3135
2020
Q4
$685K Sell
46,900
-1,900
-4% -$25.2K ﹤0.01% 2994
2020
Q3
$693K Buy
48,800
+28,000
+135% +$428K ﹤0.01% 2553
2020
Q2
$306K Sell
20,800
-500
-2% -$5.08K ﹤0.01% 3031
2020
Q1
$88K Buy
+21,300
New +$99.9K ﹤0.01% 3391
2015
Q4
Sell
-5,000
Closed -$39K 5278
2015
Q3
$39K Hold
5,000
﹤0.01% 3686
2015
Q2
$45K Hold
5,000
﹤0.01% 3612
2015
Q1
$65K Buy
+5,000
New +$65.4K ﹤0.01% 3205
2014
Q1
Sell
-800
Closed -$11K 5725
2013
Q4
$11K Sell
800
-1,300
-62% -$15.8K ﹤0.01% 4556
2013
Q3
$26K Sell
2,100
-4,000
-66% -$42.9K ﹤0.01% 4012
2013
Q2
$63K Buy
+6,100
New +$84.1K ﹤0.01% 3231

Group One Trading's GNMK Position: Q2 2021 in Review

Group One Trading sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 1,288 shares — an estimated $31K sold.

Group One Trading first reported a position in GNMK in Q2 2013 and held it in 8 quarters. The position peaked at $307K in Q4 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Group One Trading reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Group One Trading sold 1,288 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $31K.
  • Group One Trading first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 8 quarters.
  • Group One Trading's GenMark Diagnostics, Inc position peaked at $307K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Group One Trading's 13F filing for Q2 2021, filed 10 Aug 2021.